SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-02
👔
Monopar Therapeutics
@MNPR_InsiderForm 4 Filing: Robinson Chandler Surrenders for Taxes $378,137.56 of $MNPR
TAX WITHHOLDING
⚡ MATERIALITY: 5/10
corporate issuer
Monopar Therapeutics
Ticker: $MNPR
Transaction Value
$378,137.56
Price/Share: $22.30
transaction date
2026-06-30
Shares: 16,957
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Robinson Chandler, holds the title of Chief Executive Officer at Monopar Therapeutics.
On 2026-06-30, the insider transacted 16,957 shares.The shares were transacted at a weighted average price of $22.30 per share, resulting in a total market-relevant value of $378,137.56.
Executive Summary Summary
Robinson Chandler (Chief Executive Officer) had withheld for taxes $378K of $MNPR
Post-Transaction Position: 99,267 shares
SEC Accession No: 0001437749-26-022630 (CIK: 1727334)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.